If Helixate Isn't Approved by Blue Cross Blue Shield in Michigan: Eloctate Alternatives & Exception Paths
Answer Box: Getting Factor VIII Coverage When Helixate Is Denied
If Blue Cross Blue Shield of Michigan denies Helixate for hemophilia A, Eloctate is the preferred formulary alternative for 2025. Start with your hematologist requesting prior authorization for Eloctate, which requires documentation of hemophilia A diagnosis and specialist involvement. If